申请人:DAC S.r.l.
公开号:EP2033956A1
公开(公告)日:2009-03-11
This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.
这项发明涉及新的组蛋白去乙酰化酶抑制剂,其通式为(I),其中:Q是键,CH2,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH或氮,R1,R2分别是氢或C1-C6烷基,R3,R4分别是氢,卤素,C1-C6烷基,C1-C6烷氧基,C1-C6卤代烷基或C1-C6卤代烷氧基,R5和R6的进一步定义在说明书中,并且其药用盐是可以接受的。